BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Liver Int. 2022 Jul;42(7):1528-1535. doi: 10.1111/liv.15237. Epub 2022 Mar 28.
Men who have sex with men (MSM) are at risk for sexually-transmitted hepatitis C (HCV). Evidence for HCV infection in the context of pre-exposure prophylaxis (PrEP) use in North America is limited. We sought to characterize baseline HCV prevalence and incidence in MSM receiving PrEP in British Columbia (BC), Canada.
We followed individuals in the BC PrEP program from January 2018 to August 2019. We evaluated baseline prevalence and incident seroconversions (newly positive HCV antibody). A multivariable logistic regression model was performed in MSM for factors associated with HCV prevalence at enrollment, including reported prior sexually transmitted infection (STI), HIV Incidence Risk Index for MSM score, PrEP use because of a partner living with HIV, and location of residence.
The median age of the cohort was 33 years, 98.3% male, with 3058 person years (PY) of follow-up. Baseline HCV prevalence was 0.82% (31/3907 MSM enrollees) and HCV incidence (n = 3) was 0.15 per 100 PY (95% confidence interval [CI] 0.03-0.45). In multivariable analysis, initiating PrEP because of a partner living with HIV (adjusted odds ratio [aOR] 5.02; 95% CI 1.87-13.47) and prior STI (aOR 2.34; 95% CI 1.04-5.24) were associated with positive HCV status.
Baseline HCV prevalence and incidence was low amongst MSM in a population-based PrEP program in BC, Canada. HCV was associated with bridging from populations living with HIV and evidence of a reported prior STI as a PrEP indicator condition amongst MSM. PrEP initiation may be an opportunity for linkage to HCV screening and treatment.
男男性行为者(MSM)存在感染经性传播的丙型肝炎病毒(HCV)的风险。在北美,关于暴露前预防(PrEP)使用背景下 HCV 感染的证据有限。我们旨在描述加拿大不列颠哥伦比亚省(BC)接受 PrEP 的 MSM 中 HCV 基线流行率和发病率。
我们从 2018 年 1 月至 2019 年 8 月对 BC PrEP 项目中的个体进行了随访。我们评估了基线流行率和新出现的 HCV 抗体血清学转换(新阳性 HCV 抗体)的发生率。我们对 MSM 进行了多变量逻辑回归模型,以评估与 HCV 流行率相关的因素,包括报告的既往性传播感染(STI)、男男性行为者 HIV 发病率风险指数评分、因伴侣 HIV 感染而使用 PrEP,以及居住地点。
队列的中位年龄为 33 岁,男性占 98.3%,随访 3058 人年。基线 HCV 流行率为 0.82%(31/3907 名 MSM 入组者), HCV 发病率(n=3)为 0.15/100 人年(95%置信区间[CI] 0.03-0.45)。在多变量分析中,因伴侣 HIV 感染而开始使用 PrEP(调整后的优势比[aOR] 5.02;95% CI 1.87-13.47)和既往 STI(aOR 2.34;95% CI 1.04-5.24)与 HCV 阳性状态相关。
在加拿大 BC 的一项基于人群的 PrEP 项目中,MSM 的基线 HCV 流行率和发病率较低。HCV 与从 HIV 感染者人群和 MSM 中报告的既往 STI 作为 PrEP 指征疾病相关。开始 PrEP 可能是进行 HCV 筛查和治疗的机会。